side effects of tirzepatide Effects: Full Guide on Symptoms and Prevention Tirzepatide caused roughly half as

NICE guidance on obesity management emphasises the importance of individualised treatment plans that consider comorbidities and patient preferences

Of the estimated 2 million Americans with opioid use disorder, its unclear how many also have diabetes or weight-related conditions that could prompt them to seek GLP-1s and, given the medications price tag, how many could access them, even if they were interested

Same goes for MOTS-C, which is currently in an ongoing Phase 2a clinical trial evaluating its effects on insulin sensitivity in adults with prediabetes and obesity

As obesity is a key risk factor for type 2 diabetes, cardiovascular disease, and other metabolic disorders, effective pharmacological interventions are increasingly sought after

Imamura, M

While no medication is without risks, semaglutide has a strong safety record when used under proper medical supervision